Premium Nahrungsergänzungsmittel | artgerecht

Sulfasalazine: Uses, Dosage & Side Effects

Sulfasalazine is a medication used to treat chronic inflammatory conditions such as rheumatoid arthritis and Crohn's disease. It acts as an anti-inflammatory and immunomodulatory agent.

Regular tips about health Regular tips about health

Things worth knowing about "Sulfasalazine"

Sulfasalazine is a medication used to treat chronic inflammatory conditions such as rheumatoid arthritis and Crohn's disease. It acts as an anti-inflammatory and immunomodulatory agent.

What is Sulfasalazine?

Sulfasalazine is a disease-modifying antirheumatic drug (DMARD) that has been used in medicine since the 1940s. It is a combination of sulfapyridine (a sulfonamide antibiotic) and 5-aminosalicylic acid (5-ASA), linked together by an azo bond. The drug is primarily used in the treatment of inflammatory rheumatic conditions and chronic inflammatory bowel diseases.

Indications

Sulfasalazine is used for the following conditions:

Rheumatoid arthritis: Long-term treatment to slow disease progression
Crohn's disease: Treatment of active flares, particularly when the large bowel is affected
Ulcerative colitis: Treatment and prevention of disease flares
Ankylosing spondylitis (Bechterew's disease): Reduction of spinal and joint inflammation
Psoriatic arthritis: Treatment of inflammatory joint changes associated with psoriasis

Mechanism of Action

After oral administration, sulfasalazine is split in the large intestine by gut bacteria into its two active components:

5-Aminosalicylic acid (5-ASA / mesalazine): Acts locally in the bowel to reduce inflammation by inhibiting the synthesis of prostaglandins and leukotrienes.
Sulfapyridine: Is absorbed systemically and exerts immunomodulatory effects, which are particularly relevant in rheumatic diseases.

The precise immunological mechanism is not yet fully understood. It is believed that sulfasalazine inhibits the activation of immune cells, reduces the migration of inflammatory cells into tissue, and decreases the production of pro-inflammatory cytokines such as tumour necrosis factor-alpha (TNF-α) and interleukin-1.

Dosage

The dosage of sulfasalazine is adjusted individually and should always be determined by a physician. Typical dosage regimens include:

Adults (rheumatoid arthritis): Start with 500 mg per day, gradually increasing to 2,000–3,000 mg per day in 2–3 divided doses
Adults (ulcerative colitis / Crohn's disease): 2,000–4,000 mg per day in several divided doses
Children: Dosage based on body weight; medical consultation is mandatory

The medication should be taken with sufficient fluid and preferably with meals to improve gastric tolerability.

Side Effects

Sulfasalazine can cause various side effects, which may occur particularly at the beginning of therapy:

Common Side Effects

Headache, dizziness
Nausea, vomiting, stomach discomfort
Loss of appetite
Orange-yellow discolouration of urine and skin
Skin rash

Rare but Serious Side Effects

Blood count changes: Agranulocytosis, thrombocytopenia, anaemia (regular blood count monitoring is required)
Liver function disturbances: Elevation of liver enzymes
Pneumonitis: Lung inflammation
Oligospermia: Reversible reduction in sperm count in men
Stevens-Johnson syndrome: Severe skin reaction (rare)

Contraindications

Sulfasalazine must not be taken in cases of:

Known hypersensitivity to sulfonamides, salicylates, or any of the excipients
Severe renal or hepatic insufficiency
Glucose-6-phosphate dehydrogenase deficiency (G6PD deficiency)
Porphyria

Drug Interactions

The following interactions should be considered when taking sulfasalazine:

Methotrexate: Increased risk of haematological side effects
Digoxin and folic acid: Reduced absorption possible due to sulfasalazine
Anticoagulants (e.g. warfarin): Possible enhancement of anticoagulant effect
Antibiotics: May affect the breakdown of sulfasalazine in the intestine

Pregnancy and Breastfeeding

Sulfasalazine may be used during pregnancy when the benefits outweigh the risks. However, as it inhibits folic acid absorption, folic acid supplementation (at least 5 mg/day) is recommended during treatment and before a planned pregnancy. Since sulfasalazine passes into breast milk, caution is advised during breastfeeding.

References

Smolen JS et al. - EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Annals of the Rheumatic Diseases, 2020.
National Institute for Health and Care Excellence (NICE) - Rheumatoid arthritis in adults: management. NICE Guideline NG100, 2023.
European Medicines Agency (EMA) - Sulfasalazine: Summary of Product Characteristics, 2023.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category